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mid›1990s in Afghanistan, for example, Meddings
found a decline in the rate of weapons related injury,
before and after a particular region came under
uncontested control, of only 20›40% when weapons
remained in circulation.12
Supply side strategies such as buyback and amnesty
schemes have been tried in countries such as the
United Kingdom and Australia. In response to massa›
cres at Dunblane and Port Arthur, those countries
tightened regulations, the former banning handguns
and the latter semiautomatic rifles. British citizens vol›
untarily turned in 250 000 weapons, while the Austral›
ian buyout programme netted 750 000. Law enforce›
ment officials in both countries affirm the effectiveness
of these measures in reducing damage by these
weapons.
Many argue that a supply side approach alone is
inadequate, and various demand side measures have
been proposed. Awareness building and educational
programmes to promote cultures of peace; inter›
national norms that stigmatise the possession of guns;
and programmes to reintegrate former combatants
into society and to provide real economic opportuni›
ties have all been postulated to reduce harm from
small arms, but are more difficult subjects of study. In
Mozambique a unique project, Tools for Arms,
combines supply and demand side approaches. The
buyback of weapons, the metal of which is turned into
art, provides compensation for gun owners, giving
them new economic opportunities.
International humanitarian law may be applied to
restrict weapons that cause damage disproportionate
to war aims. Whole classes of weapons could be
banned from civilian possession, just as landmines and
other indiscriminately harmful weapons have been
banned from military and civilian use. Although it
seems clear that restrictions on the possession of
weapons are necessary to prevent harm due to small
arms, such restrictions are fiercely opposed by highly
organised, wealthy, and influential groups such as
America’s National Rifle Association. The failure to
reach meaningful agreement to control illegal manu›
facture and trafficking in small arms at the recent
United Nations conference on the illicit trade in small
arms and light weapons was partly the result of the
lobbying of these groups.
Public health models could be used to evaluate the
effectiveness of each preventive approach. Inter›
national Physicians for the Prevention of Nuclear War
(IPPNW) has used the public health paradigm to call
for the abolition of nuclear weapons and to support
the global ban on landmines. With the convening of an
international medical conference on small arms last
autumn in Helsinki, IPPNW announced its intent to
campaign for policies that can reduce firearms related
injuries. The conference drew more than 200
participants—physicians, researchers, social scientists,
peace activists, representatives of governments and
international agencies, and students—from six conti›
nents to address gaps in our knowledge, propose areas
for research, and ponder educational and advocacy
strategies.
The next steps will be to determine data on which
to base recommendations for policy change and com›
munity action; standardise databases and collection
methods across the world; heighten awareness about
the public health and social consequences of small
arms among local, national, and international policy
makers; and inform professional colleagues, students,
and the public about the multiple causes and the dev›
astating consequences of small arms violence.
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Health care and the European Union
Profound but uncertain consequences for national health systems
Slowly, in health and social affairs ministries acrossEurope, the realisation is dawning that EuropeanUnion law has profound consequences for the
organisation of national healthcare systems. Even in the
United Kingdom, which for many years was in a state of
active denial about the influence of Europe, ministers
are looking at how to exploit the opportunities offered
by provisions on free movement of patients (to France)
and professionals (bringing teams of German surgeons
to operate at weekends in NHS hospitals).
Yet the scope for action is often uncertain. A failure
to address health care explicitly at a European level
means that the evolving legal situation is based largely
on policies designed to address broad principles, in
particular the free movement of goods, services,
people, and capital. These are then applied to the
health sector in rulings on specific cases brought
before the European Court of Justice, but leaving
uncertainty as to how they should be interpreted in
similar but slightly different circumstances. The
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situation is complicated further by the changing nature
of healthcare delivery, such as public and private part›
nerships within publicly funded systems, potentially
bringing new areas within the scope of competition
law.
As Duncan notes in his article this week (p 1027),1
the consequences for the United Kingdom of the
changing European environment are likely to be con›
siderable. Some are obvious. Directives on doctors and
on working time have already had important
implications for patterns of medical staffing and,
potentially, for the viability of many district hospitals.
But others are less clear. Recent rulings that citizens
can obtain health services abroad without obtaining
prior authorisation from funders raises important and
as yet largely unexplored issues.2 When is a decision to
deny treatment abroad justified on grounds of clinical
effectiveness and when is it an unwarranted block on
provision of services? How long is what the court terms
“undue delay,” which is sufficient reason for patients to
demand that their treatment be paid for in another
country where it can be offered sooner? It is almost
certainly much less than the time most people wait for
definitive treatment in the United Kingdom. But how
much less, and what are the consequences for primary
care trusts with limited budgets?
Further questions relate to the implications of the
new British system of revalidation. Will it apply to
German surgical teams visiting at weekends? The
European Court of Justice has consistently held that
the right of establishment allows professionals to work
in more than one member state,3 a view confirmed by
two recent rulings by the European Free Trade Area
Court,4 5 but they must adhere to established
professional standards. How will this work in practice?
It is increasingly clear that it is necessary to
consider possible implications of European law when›
ever change of any sort is contemplated. What might
the European Court of Justice say about the
recommendation in the Kennedy report6 into heart
surgery at Bristol Royal Infirmary that the National
Institute for Clinical Excellence, established to advise
the NHS on what interventions it should provide,
should be at arm’s length from government? As the
institute plays an important role in reimbursement
decisions, will European law permit this role to be ful›
filled by a non›state body?
And it is easy to forget that the NHS does more
than just provide health care. NHS trusts are involved
in training and research, and here too current arrange›
ments could be open to challenge by private research
teams on grounds of competition. The application of
competition law to trusts is also likely to change if they
are permitted to keep their surpluses and engage in
more entrepreneurial activities. This is likely to require
creation of new legal and financial structures to avoid
legal challenges.
Yet some bodies are already taking full account of
European Union law. In two recent rulings, the Office
of Fair Trading and the Competition Commission both
referred extensively to European case law in decisions
on pharmaceutical pricing.7
It is increasingly clear that the present uncertain
situation cannot continue. A recent report by the high
level committee on health of the European Commis›
sion8 suggested that internal market rules should take
full account of the interests of patients and health serv›
ices and not just purely economic interests. It also rec›
ommended reformulation of the European Union
competencies in health with the objective of moving all
related health powers into one treaty article that would
clarify roles and responsibilities.
However, this may not be sufficient. The next treaty
revision must consider explicitly how the European
Union can ensure that the social nature of health care in
Europe is not unintentionally undermined. But this will
take time. In the short term, three things are possible.9
Firstly, much greater coordination within the European
Commission among those responsible for the many
issues that have implications for health care is needed.
Secondly, there must be a greater use of the newly
established system of open coordination of national
social policies.10 This system, which has formally estab›
lished mechanisms to learn from the experience of
others while taking account of national circumstances,
provides an opportunity to promote best practice by
increasing exchange of information on what works and
what does not, and in what circumstances. In many
cases it will be possible to develop shared approaches
to common problems, but this mechanism respects
historical, political, and cultural diversity. It does not
force the harmonisation of processes that, while pursu›
ing the same goal, are organised in ways that are
incompatible with each other.
Finally, the European Union must establish, as soon
as possible, a system that can monitor the evolving
impact that European Union law has on healthcare
systems and propose remedies when unintended
effects arise.
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